CVS Health anticipates a notable uptick in fourth-quarter revenues, primarily powered by a 6.5% year-over-year increase in prescription volumes and the expansion of its HealthHUB locations. Management forecasts pharmacy same-store script growth of between 5% and 7%, supported by seasonal flu demand and a growing portfolio of specialty medications. The consumer wellness business, which contributes roughly 12% of total revenues, is expected to benefit from new in-store clinical services and over-the-counter health product introductions, potentially lifting segment revenues by $400 million compared with the prior year quarter.

Following an early restructuring initiative that delivered $1.2 billion in annualized cost savings, CVS stands better prepared for downward pressure on Medicare Advantage rates. The company’s pharmacy benefit management (PBM) unit represents 20% of consolidated revenues and has trimmed administrative expenses by 8% year-to-date. Management has also reduced exposure to lower-margin Medicare contracts by nearly 15% since last year’s renewal cycle. These actions helped offset a 1.8% cut in government reimbursement rates and position CVS to maintain pharmacy gross margins near the high end of its historical 28% to 30% range.

In the latest 13F filings, Strengthening Families & Communities LLC increased its position in CVS Health by 1,923.9% during the third quarter, acquiring an additional 30,090 shares and bringing its total holding to 31,654 shares. That stake was valued at $2.37 million at quarter-end. QRG Capital Management also grew its position by 173.9%, adding 58,984 shares to reach 92,896 shares valued at $6.41 million. Overall institutional ownership now stands at 80.7%, indicating sustained confidence among large investors ahead of the impending earnings release.